Skills this job asks for
ComplianceLeadershipReconciliationPharmacy
Add your CV (free) to see which of these your CV is missing.
Sponsorship verdict
Sponsorship possible
One solid signal, not two. Worth applying, and worth asking about sponsorship early.
-
✓
Employer is on a government sponsor recordThe US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Mar 2026) — the step every H-1B hire needs first.
-
?
The posting doesn’t mention sponsorshipSilence isn’t a refusal — ask the recruiter before investing much time.
-
?
No salary bar for this routeH-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area.
-
✓
Confirmed live todayWhen a source last listed this job as open.
Details and sources
- Employer is on a government sponsor record
- The US Department of Labor certified 1 H-1B/E-3 labor condition applications for this employer between Oct 2025 and Jun 2026 (latest Mar 2026) — the step every H-1B hire needs first. Source: LCA disclosure data (US Department of Labor (OFLC)).
- No salary bar for this route
- H-1B has no fixed salary bar: the employer must pay at least the prevailing wage for the role and area. Cap-subject employers enter a lottery weighted by wage level. Source: https://www.federalregister.gov/documents/2025/12/29/2025-23853/weighted-selection-process-for-registrants-and-petitioners-seeking-to-file-cap-subject-h-1b, rules effective 2026-02-27.
US H-1B: cap-subject employers enter a lottery weighted by wage level — Level I gets 1 entry, Level IV gets 4 (DHS projected selection odds ≈15% at Level I to ≈61% at Level IV). Universities and non-profit research employers are cap-exempt. The $100,000 fee for new petitions from abroad is currently blocked by a court order (appeal pending).
A verdict summarises public evidence. It is not legal advice and never a guarantee: the employer and the immigration authority decide. Sign in to factor in where you can already work.
About the role
About Stoke:
Stoke Therapeutics (Nasdaq: STOK), is a biotechnology company dedicated to restoring protein expression by harnessing the body’s potential with RNA medicine. Using Stoke’s proprietary TANGO (Targeted Augmentation of Nuclear Gene Output) approach, Stoke is developing antisense oligonucleotides (ASOs) to selectively restore naturally-occurring protein levels. Stoke’s first medicine in development, zorevunersen, has demonstrated the potential for disease modification in patients with Dravet syndrome and is currently being evaluated in a Phase 3 study. Stoke’s initial focus are diseases of the central nervous system and the eye that are caused by a loss of ~50% of normal protein levels (haploinsufficiency). Proof of concept has been demonstrated in other organs, tissues, and systems, supporting broad potential for Stoke’s proprietary approach. Stoke is headquartered in Bedford, Massachusetts. For more information, visit https://www.stoketherapeutics.com/
Position Purpose:
We are seeking a Sr. Director, PV Operations & Compliance to create, direct and manage the company’s PV infrastructure in support of its first commercial product for a first-in-class antisense oligonucleotide (ASO) therapy in a rare pediatric neurological disease. The Sr. Director, Pharmacovigilance Operations & Compliance is a newly created role and a genuine opportunity to shape the scientific infrastructure of PV department at a critical inflection point.
This position is accountable for PV operations for Stoke which includes oversight of safety operations across the portfolio including case processing, database strategy, vendor oversight & governance, inspection readiness, contracts, training and operational strategies related to safety data exchange agreements for the company’s business partners and alliances. The candidate will work collaboratively with internal staff in defining and implementing operational infrastructure and strategies and must build and maintain effective relationships with key strategic internal and external stakeholders including the hiring and training of PV personnel. The role is best suited for someone who is comfortable operating in a small, fast-paced biotech environment. This position reports to the Vice President, Pharmacovigilance.
Key Responsibilities:
• Provide strategic leadership for global pharmacovigilance operations, including case management, vendor oversight, and aggregate reporting.
• Direct the development of the PV quality management system including SOPS, Work Instructions, and other guidance documents, in collaboration with internal PV and Quality personnel.
• Establish and maintain oversight and coordination of PV activities (e.g., contracts, safety data exchange agreements, training, reconciliation related to organized data collection systems used by the company (e.g., Market Research, investigator-run-trials, Compassionate Use/Expanded Use, Patient Support Programs)
• Own the strategic design and implementation of the company’s PV training program, spanning internal staff, field staff and external partners including patient support programs, specialty pharmacy distributors, and market research vendors, with role-specific content. Partner with Legal, Compliance, Commercial and Medical Affairs to embed training requirements into vendor contracts and onboarding, with KPIs to track effectiveness through commercial launch and beyond.
• Lead effective vendor management strategies for PV-related activities. Develop effective business models optimizing internal and contract resources and ensure adequate documentation of vendor oversight.
• Establish and oversee implementation of company standards related to post-marketing surveillance, track productivity and monitor quality /cost of outsourced activ
Apply on employer site ↗